Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicinesVANCOUVER, British Columbia--(BUSINESS ...
Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End MarketsExpands Mechanical Services ...
Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage ...
SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition ...
Appoints R. Brent Jones CFOReaffirms 2026 OutlookNORTH BETHESDA, Md.--(BUSINESS WIRE)--$ESAB #ESAB--ESAB Corporation ("ESAB" or the "Company") (NYSE: ESAB), a focused premier industrial compounder, ...
New market-intelligence report finds post-acute providers are prioritizing practical technologies and managed services that ...
Affordable, cloud-based SaaS solution automates E2B (R2) to E2B (R3) conversion for small and mid-size pharma ...
Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient ...
Regulatory News:Celyad Oncology (Euronext: CYAD) (the “Company”), today announces its financial results for the fiscal year ...
POLAR is a randomized, double-blind, placebo-controlled study that enrolled 43 patients with PMM2-CDG across 15 sites ...
IND approval from the FDA allows CanWell Pharma to assess the safety, tolerability and pharmacokinetics of CAN016 in a Phase ...
GlyphAgo achieved therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or ...